Vimarsana
Biggest News Aggregation in the World

Page 2 - Alxo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alxo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alxo Today - Breaking & Trending Today

ALX Oncology (NASDAQ:ALXO) Hits New 12-Month High at $16.00 - Vimarsana News

ALX Oncology (NASDAQ:ALXO) Hits New 12-Month High at $16.00

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report)’s stock price reached a new 52-week high during trading on Tuesday . The company traded as high as $16.00 and last traded at $15.41, with a volume of 81916 shares traded. The stock had previously closed at $15.65. Analyst Upgrades and Downgrades Several analysts have issued […]

Source: wkrb13.com
ALX Oncology (NASDAQ:ALXO) Trading Up 5.3% - Vimarsana News

ALX Oncology (NASDAQ:ALXO) Trading Up 5.3%

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report)’s share price was up 5.3% during trading on Wednesday . The stock traded as high as $14.38 and last traded at $14.31. Approximately 83,390 shares traded hands during mid-day trading, a decline of 71% from the average daily volume of 288,732 shares. The stock had previously […]

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Short Interest Update - Vimarsana News

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Short Interest Update

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) was the target of a significant decrease in short interest during the month of December. As of December 31st, there was short interest totalling 3,770,000 shares, a decrease of 6.7% from the December 15th total of 4,040,000 shares. Approximately 13.8% of the company’s stock are short […]

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Recommendation of "Buy" from Brokerages - Vimarsana News

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Recommendation of "Buy" from Brokerages

Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) have earned a consensus rating of “Buy” from the eight brokerages that are currently covering the company, Marketbeat reports. Eight investment analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have updated their coverage on the […]

ALX Oncology (NASDAQ:ALXO) Upgraded at Jefferies Financial Group - Vimarsana News

ALX Oncology (NASDAQ:ALXO) Upgraded at Jefferies Financial Group

Jefferies Financial Group upgraded shares of ALX Oncology (NASDAQ:ALXO – Free Report) from a hold rating to a buy rating in a research report released on Friday, MarketBeat Ratings reports. The firm currently has $18.00 target price on the stock, up from their prior target price of $8.00. Several other analysts have also weighed in […]